RE:RE:ACST - NEWS OUT -2 dollar next weekHere are some thoughts for next week quarter release:
- Management forgot to press release the shares issuance on the bond $1.9M, (unless they paid in cash).
- I hope they will disclose full randomization and between 40-50% completed the trial.
- Timeframe for phase 3, last patient visit ; April, May or June ?
- Timeframe of when they will release results : September ?
- How they will expend production, do they have a plan to expend the production if Phase 3 is positive ?
- Update on the commercialisation, are they waiting trial results to maximise deal value, status of discussions, what is the plan for north america, china, etc ?
- 2019 is crucial, Acasti need to expend board team to more than 4 individuals. They need financial experts and scientists to support the management.
Again, the market under estimate the potential of all the 22 secondary end points.
I hope to see SP around $3US by next summer and potential 8$-10$ following positive results.
Good luck to all.